Search
Voyager Therapeutics Inc
VYGRAdd to Watchlist
3.780USD
+0.180+5.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
208.69MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-02The current earnings forecast score of Voyager Therapeutics Inc is 9.09, ranking 14 out of 387 in the Biotechnology & Medical Research industry. The average price target is 12.00, with a high of 25.00 and a low of 8.00.
Analyst Rating
Based on
11
analysts
Strong Buy
Current Rating
14.889
Target Price
+313.58%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
Voyager Therapeutics Inc
VYGR
11
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Voyager Therapeutics Inc's expected revenue for the next quarter?
Voyager Therapeutics Inc's expected revenue is 4.73M.
What is Voyager Therapeutics Inc's price target?
Analysts forecast that Voyager Therapeutics Inc's price target is USD 12.00, with the highest forecast at USD 25.00 and the lowest forecast at USD 8.00.
How have Voyager Therapeutics IncVYGR's recent earnings per share performed?
The market expectation was USD -0.47, while Voyager Therapeutics IncVYGR's earnings per share (EPS) for the previous quarter was USD -0.47. EPS for the next quarter is expected at USD -0.48.
What is the analyst rating for Voyager Therapeutics Inc?
Based on the ratings of Voyager Therapeutics Inc's stock from 11 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.